EGFR and esophageal squamous cell carcinoma: Mechanism studies, as provided in this report, suggest that the enhanced radiotherapy effect by Nimotuzumab in EGFR high-expression ESCC cells might be dependent on the up-regulated expression of IGFBP-3 through EGFR-dependent pathway.